Former Chief Executive Officer · Cogent Biosciences, Inc. (COGT)

Charles Wilson

A named executive officer of Cogent Biosciences in every fiscal year CompBrief holds from FY2017 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,796,751

Salary $481,340Stock awards $0

FY2019: $1,749,153

3rd of 4 named executive officers at Cogent Biosciences by FY2020 total.

4 named officers on file for Cogent Biosciences, FY2020

Charles Wilson’s pay file — $29

  • 4 fiscal years of pay, line by line
  • COGT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cogent Biosciences’s whole pay program stands against its peers

  • Cogent Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on COGT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Charles Wilson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Charles Wilson compensation by year

Cogent Biosciences Summary Compensation Table · all 4 fiscal years held
In US dollars, as Cogent Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020
Salary$360,000$486,000$543,417$481,340
Bonus$113,400$248,160$264,000$0
Stock awards$0—$0$0
Option awards$0$1,340,955$941,736$0
Non-equity incentive$0—$0$0
Pension and deferred compensation$0—$0$0
All other$0—$0$1,315,411
Total$473,400$2,117,115$1,749,153$1,796,751

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cogent Biosciences, Inc. DEF 14A filed April 30, 2021, accession 0001193125-21-144950, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cogent Biosciences, Inc. filed document, accession 0001193125-21-144950. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

$473K
$2.1M
$1.7M
$1.8M
FY17
FY18
FY19
FY20
SalaryBonusOption awardsAll other

Cogent Biosciences’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Andrew RobbinsChief Executive Officer$17,859,744
John GreenChief Financial Officer$2,139,245
Charles Wilson · this pageFormer Chief Executive Officer$1,796,751
Jessica SachsChief Medical Officer$1,189,457

The full Cogent Biosciences compensation record

free company brief

This page is one person within Cogent Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Cogent Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cogent Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Charles Wilson's compensation dossier · One-time report. No refunds.